TrialJournal of the American Heart Association2020

Effects of Epeleuton, a Novel Synthetic Second-Generation n-3 Fatty Acid, on Non-Alcoholic Fatty Liver Disease, Triglycerides, Glycemic Control, and Cardiometabolic and Inflammatory Markers.

John Climax et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.